Cerora
Subscribe to our mailing list
* indicates required

Who We Are

Cerora, Inc. (CI) is a healthcare information technology company focused on providing accessible and affordable neuro diagnostic information with a particular focus on concussion (mTBI) and Alzheimer’s disease.

We deliver actionable diagnostics information regarding brain health and function to patients, physicians and companies. To date, there is no portable, objective, accurate and affordable diagnostic tool to assess brain function and to assist in patient decision making for neurologic and neuropsychiatric diseases.

Cerora is filling this gap with Borealis™ by combining (i) advances in wireless dry contact EEG sensor technology with (ii) other bio-sensor data and (iii) proprietary activated data acquisition paradigms via (iv) an innovative Neuro Diagnostics as a Service information technology infrastructure.

Using Cerora Borealis™

  • Neurologists and psychiatrists will have additional medical device information to aid in the diagnosis and manangemement of neurologic and pyschiatric conditions.
  • Pharmaceutical and biotechnology companies can gather objective biomarker evidence of test drug compound safety and effectiveness.
  • Cerora will seek FDA 510(k) clearance and eventually PMA approval for its medical devices and diagnostic information.
  • The military will be able to quickly assess the severity of head trauma in soldiers in the field for "return to duty" decisions.
  • Eventually after further FDA review, people with a family history of Alzheimer's disease and/or cognitiive impairment will be able to keep detailed quantitative records of their historic brain functionality.

What We Do

Cerora is working with various scientific and clinical collaborators around the world to develop its leading edge Portable Objective Neuro Diagnostics as a Service technology - Borealis™ .

Cerora Borealis™ can be used to aid in the assessment and management of brain health in a variety of settings, and to diagnose neurologic injuries such as mild Traumatic Brain Injury (mTBI or concussion) and diseases such as Alzheimer's and Mild Cognitive Impairment, as well as Post Traumatic Stress Disorder (PTSD), depression, schizophrenia, and other neuropsychiatric disorders.

Because of its portable, objective and accurate nature, it can also accelerate pharmaceutical and life science company clinical development of novel CNS therapeutic products. Other medical device companies can benefit from Cerora's bio-sensor biomarker platform during the development of their products and services.

© 2014 Cerora, Inc.   ~   All Rights Reserved
Website managed by David Taylor Design